34
Participants
Start Date
July 8, 2015
Primary Completion Date
April 12, 2024
Study Completion Date
April 12, 2024
Nintedanib
Prednisone
Placebo
Memorial Sloan Kettering Cancer Center, New York
Memorial Sloan Kettering Westchester, Harrison
Memorial Sloan Kettering Nassau, Uniondale
Memorial Sloan Kettering Cancer Center @ Suffolk, Commack
Lehigh Valley Health Network (Data Collection Only), Allentown
MD ANDERSON CANCER CENTER (Data Collection Only), Houston
Myriad Genetic Laboratory (Data or Specimen Analysis Only), Salt Lake City
Brigham and Women's Hospital (Data Collection Only), Boston
Memorial Sloan Kettering Cancer Center at Basking Ridge, Basking Ridge
Memorial Sloan Kettering Monmouth, Middletown
Memorial Sloan Kettering Bergen, Montvale
Memorial Sloan Kettering at Mercy Medical Center, Rockville Centre
Collaborators (1)
Boehringer Ingelheim
INDUSTRY
Memorial Sloan Kettering Cancer Center
OTHER